AU Patent

AU1677095A — Oral dosage form of desmopressin (ddavp)

Assigned to Alkermes Controlled Therapeutics Inc · Expires 1995-08-01 · 31y expired

What this patent protects

Patent listed against OxyContin.

Drugs covered by this patent

Patent Metadata

Patent number
AU1677095A
Jurisdiction
AU
Classification
—
Expires
1995-08-01
Drug substance claim
No
Drug product claim
No
Assignee
Alkermes Controlled Therapeutics Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.